New York State Common Retirement Fund’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-525,881
Closed -$1.58M 3195
2019
Q4
$1.58M Buy
+525,881
New +$1.37M ﹤0.01% 1722

Other funds holding BMY.RT

New York State Common Retirement Fund's BMY.RT Position: Q1 2020 in Review

New York State Common Retirement Fund sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2020, closing a stake of 525,881 shares — an estimated $1.58M sold.

New York State Common Retirement Fund first reported a position in BMY.RT in Q4 2019 and held it in 1 quarter. The position peaked at $1.58M in Q4 2019. 581 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2020.

  • New York State Common Retirement Fund reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
  • New York State Common Retirement Fund sold 525,881 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2020, an estimated $1.58M.
  • New York State Common Retirement Fund first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 1 quarter.
  • New York State Common Retirement Fund's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $1.58M in Q4 2019.
  • 581 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2020.

Based on New York State Common Retirement Fund's 13F filing for Q1 2020, filed 6 May 2020.